Joachim Frey
11Patents
3h-index
13Co-inventors
53Inventor score
Filing activity: May 30, 1997 → Jan 28, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6783764B1 | Actinobacillus pleuropneumoniae subunit vaccine | Chemistry; Metallurgy | 6 | Expired |
| US6013266A | Live attenuated bacteria of the species Actinobacillus pleuropneumoniae | Chemistry; Metallurgy | 6 | Expired |
| US7232569B2 | Type III secretion pathway in aeromonas salmonicida, and uses therefor | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6770275B1 | Live attenuated RTX-producing bacteria of the family pasteurellaceae | Chemistry; Metallurgy | 2 | Expired |
| US7851197B2 | Exoenzyme toxin of Aeromonas salmonicida, and uses therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US7351550B2 | Exoenzyme toxin of Aeromonas salmonicida, and uses thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7833536B2 | Mycoplasma subunit vaccine | Human Necessities | 0 | Active |
| US7815896B2 | Type III secretion pathway in Aeromonas salmonicida and uses therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US7579011B2 | Exoenzyme toxin of Aeromonas salmonicida, and uses therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US7538208B2 | Type III secretion pathway in Aeromonas salmonicida, and uses therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US8709437B2 | Clostridium chauvoei polypeptide, DNA encoding the polypeptide and a vaccine comprising the polypeptide | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.